NEUP

Neuphoria Therapeutics Inc.

$3.38 -0.17 (-4.79%) At close · Jul 2

Market Cap

$18.27M

5,404,551

Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.

Date	Insider	Role	Type	Shares	Price	Value	After
2026-01-20	Davies Peter Miles Winston	Director	Award	8,537	—	—	15,320
2026-01-20	Fisher Alan	Director	Award	17,073	—	—	30,731
2026-01-20	Ryan Jane	Director	Award	8,537	—	—	15,550
2026-01-20	Wilson David Ian	Director	Award	8,537	—	—	15,412
2025-10-21	Lynx1 Capital Management LP	10% Owner	Buy	639,110	$5.14	$3,283,108	875,328
2025-08-27	Papapetropoulos Spyros	Director, President and CEO	Award	34,559	$8.27	$285,803	74,088
2025-04-16	Ryan Jane	Director	Award	6,783	—	—	7,013
2025-04-16	Papapetropoulos Spyros	Director, President and CEO	Award	27,000	$5.16	$139,320	39,529
2025-04-16	Davies Peter Miles Winston	Director	Award	6,783	—	—	6,783
2025-04-16	Fisher Alan	Director	Award	13,566	—	—	13,658
2025-04-16	Wilson David Ian	Director	Award	6,783	—	—	6,875
2024-07-01	Weaver Aaron Ngoc Dung	Director	Other	0	—	—	0
2024-07-01	Cunningham Timothy M.	interim CFO	Other	0	—	—	0

Showing 1–13 of 13 transactions

Key facts CIK 1191070 CUSIP 64136E102 Visit website Investor relations